CytoDyn CYDY
OTC CYDY
$0.20 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

CytoDyn (CYDY) Revenue (2021 - 2022)

Updated

CytoDyn (CYDY) posted Revenue of $34,000 for fiscal Q4 2022 (quarter ended May 31, 2022).

Analysis

CytoDyn (CYDY) Revenue (2021 - 2022) Analysis & Trends

For FY2022 (ended May 31, 2022), CytoDyn's Revenue came in at $300,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 CytoDyn 274.70 Mn 274.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
May 31, 2022 34,000.00
Nov 30, 2021 225,000.00
Aug 31, 2021 41,000.00
API Access

CytoDyn Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=CYDY&period=max&api_key=YOUR_API_KEY